Repligen Corporation (RGEN) Social Stream



Repligen Corporation (RGEN): $159.93

0.28 (-0.17%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add RGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#213 of 359

in industry

REPLIGEN CORP (RGEN) Price Targets From Analysts

Use the tables below to see what analysts covering REPLIGEN CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 10 $368 $240 $312.555 $158.99 96.59%
2021-12-20 10 $368 $240 $315.888 $158.99 98.68%
2022-02-18 10 $368 $240 $310.333 $158.99 95.19%
2022-03-01 10 $368 $210 $281.444 $158.99 77.02%
2022-04-28 10 $330 $210 $257.666 $158.99 62.06%
2022-06-01 9 $330 $170 $249.888 $158.99 57.17%
2022-07-20 10 $330 $170 $246.888 $158.99 55.29%
2022-08-03 10 $330 $170 $248.555 $158.99 56.33%
2022-09-05 10 $330 $210 $267.444 $158.99 68.21%
2022-10-23 7 $320 $210 $257.125 $158.99 61.72%
2022-10-25 8 $320 $210 $257.125 $158.99 61.72%
2022-11-01 7 $320 $210 $254.625 $158.99 60.15%
2022-11-02 8 $270 $200 $240.5 $158.99 51.27%
2022-12-07 9 $270 $190 $232.111 $158.99 45.99%
2023-01-03 10 $270 $180 $226.9 $158.99 42.71%
2023-02-02 10 $270 $180 $223.9 $158.99 40.83%
2023-02-23 10 $270 $180 $215.8 $158.99 35.73%
2023-03-06 10 $250 $180 $213.8 $158.99 34.47%
2023-03-07 10 $250 $180 $212.8 $158.99 33.84%
2023-04-20 11 $250 $180 $214.363 $158.99 34.83%
2023-05-03 11 $250 $165 $213 $158.99 33.97%
2023-06-01 11 $240 $157 $199.272 $158.99 25.34%
2023-06-28 11 $240 $157 $198.363 $158.99 24.76%
2023-07-06 11 $240 $156 $198.272 $158.99 24.71%
2023-07-21 12 $240 $156 $194.818 $158.99 22.53%
2023-08-01 11 $240 $156 $194.818 $158.99 22.53%
2023-08-02 11 $240 $156 $193 $158.99 21.39%
2023-08-04 11 $240 $156 $193.909 $158.99 21.96%
2023-09-06 12 $240 $165 $196.818 $158.99 23.79%
2023-09-13 12 $240 $165 $196.454 $158.99 23.56%
2023-09-22 13 $240 $165 $197.583 $158.99 24.27%

The Trend in the Analyst Price Target


Over the past 48 weeks, RGEN's average price target has gone down $59.54.

Over the past 48 weeks, RGEN's average upside potential has been 23.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-15 10 270 180 226.900 168.25 34.86%
2023-07-31 11 240 156 194.818 171.56 13.56%
2023-08-16 12 240 165 196.818 167.98 17.17%
2023-09-15 13 240 165 197.583 165.50 19.39%
2023-09-20 13 240 165 197.583 168.58 17.2%

RGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 10 1 2 0 0 13

The Trend in the Broker Recommendations


RGEN's average broker recommendation rating worsened by 0.2 over the prior 41 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • REPLIGEN CORP's average analyst price target is higher than 3754.87% of all US stocks.
  • REPLIGEN CORP's upside potential (average analyst target price relative to current price) is higher than 1054.98% of Pharmaceutical Products stocks.
  • REPLIGEN CORP's number of analysts covering the stock is greater than 1160.11% of stocks in the large market cap category.
  • REPLIGEN CORP's variance in analysts' estimates is lower than -1080.73% of Pharmaceutical Products stocks.

Stocks similar to REPLIGEN CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DNA, CGC, and TLRY.

What is the outlook for RGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!